RaQualia Pharma Inc.
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
4579 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 名古屋市中村区名駅南一丁目２１番１９号
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
RaQualia Pharma Inc. is a research and development-focused drug discovery company that originated as a spin-off from Pfizer's research laboratories. The company specializes in the discovery and early-stage development of novel pharmaceutical compounds, or 'seeds' for new drugs, with a focus on small molecules. Its primary business model involves creating these development compounds and then generating revenue through out-licensing agreements and partnerships with other pharmaceutical companies for late-stage development and commercialization. RaQualia actively leverages an open collaboration network with academic and industry partners to advance its pipeline. The company is also expanding into new therapeutic modalities, such as targeted protein degradation, to address previously 'undruggable' targets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 08:58 |
Report Publication Announcement
確認書
|
Japanese | 8.2 KB | ||
| 2025-08-14 08:57 |
Interim Report
半期報告書－第18期(2025/01/01－2025/12/31)
|
Japanese | 229.8 KB | ||
| 2025-04-18 08:30 |
Major Shareholding Notification
臨時報告書
|
Japanese | 21.1 KB | ||
| 2025-03-31 09:01 |
Registration Form
訂正有価証券届出書（参照方式）
|
Japanese | 155.4 KB | ||
| 2025-03-31 08:31 |
Registration Form
訂正確認書
|
Japanese | 8.2 KB | ||
| 2025-03-31 08:30 |
Annual Report
訂正有価証券報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 811.9 KB | ||
| 2025-03-26 08:05 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 158.4 KB | ||
| 2025-03-26 07:52 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 22.7 KB | ||
| 2025-03-26 07:51 |
Registration Form
確認書
|
Japanese | 8.2 KB | ||
| 2025-03-26 07:50 |
Governance Information
内部統制報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 23.1 KB | ||
| 2025-03-26 07:49 |
Annual Report
有価証券報告書－第17期(2024/01/01－2024/12/31)
|
Japanese | 1.4 MB | ||
| 2025-03-21 07:30 |
Registration Form
有価証券届出書（参照方式）
|
Japanese | 282.6 KB | ||
| 2024-12-13 08:00 |
Board/Management Information
臨時報告書
|
Japanese | 20.7 KB | ||
| 2024-10-01 09:04 |
Share Issue/Capital Change
訂正臨時報告書
|
Japanese | 35.8 KB | ||
| 2024-09-13 08:31 |
Share Issue/Capital Change
臨時報告書
|
Japanese | 37.9 KB |
Automate Your Workflow. Get a real-time feed of all RaQualia Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for RaQualia Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
